Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
11.79
+0.18 (1.55%)
Jun 12, 2025, 2:45 PM CST
-9.31%
Market Cap 19.06B
Revenue (ttm) 3.80B
Net Income (ttm) 733.67M
Shares Out 1.62B
EPS (ttm) 0.44
PE Ratio 26.91
Forward PE 16.76
Dividend 0.10 (0.86%)
Ex-Dividend Date Jun 5, 2025
Volume 15,937,804
Average Volume 14,911,108
Open 11.60
Previous Close 11.61
Day's Range 11.54 - 12.08
52-Week Range 10.12 - 16.01
Beta 0.61
RSI 61.24
Earnings Date Aug 29, 2025

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.